Aldose reductase inhibition suppresses airway inflammation

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 339-345

  Yadav, Umesh C S ^a   Ramana, Kota V ^a   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Airway inflammation; Aldose reductase; Asthma; Ragweed pollen extract; ROS

Indexed keywords

ALDEHYDE REDUCTASE; ALDEHYDE REDUCTASE INHIBITOR; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CELL COUNT; CELL DEATH; CELL INFILTRATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY TEST; DRUG EFFICACY; ENZYME INHIBITION; EOSINOPHIL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; RESPIRATORY TRACT INFLAMMATION; TREATMENT RESPONSE;

ALDEHYDE REDUCTASE; AMBROSIA; ANIMALS; APOPTOSIS; ASTHMA; ENDOTOXINS; ENZYME INHIBITORS; EOSINOPHILS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; OVALBUMIN; POLLEN; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

AMBROSIA; ANIMALIA; MUS;

EID: 79957539666     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.02.014     Document Type: Conference Paper

References (45)

1. M. Masoli, D. Fabian, S. Holt, R. Beasley, The global burden of asthma: executive summary of the GINA Dissemination Committee Report, Allergy 59 (2004) 469-478. (Pubitemid 38580764)
2. L. Akinbami, Office of Analysis and Epidemiology, CDC National Center for Health Statistics E-stat, Asthma Prevalence, Health Care Use and Mortality: United States, 2003-05, 2010 (accessed 31.8.10.) http://www.cdc.gov/nchs/data/ hestat/asthma03-05/asthma03-05.htm#fig1.
3. S. Kamble, M.J. Bharmal, Incremental direct expenditure of treating asthma in the U.S., J. Asthma 46 (2009) 73-80.
4. A.J. Nauta, F. Engels, L.M. Knippels, J. Garssen, F.P. Nijkamp, F.A. Redegeld, Mechanisms of allergy and asthma, Eur. J. Pharmacol. 585 (2008) 354-360.
5. G. D'Amato, L. Cecchi, M. D'Amato, G. Liccardi, Urban air pollution and climate change as environmental risk factors of respiratory allergy: an update, J. Invest. Allerg. Clin. Immunol. 20 (2010) 95-102.
6. D.K. Agrawal, Z. Shao, Pathogenesis of allergic airway inflammation, Curr. Allergy Asthma Rep. 10 (2010) 39-48.
7. J.P. Parsons, J.G. Mastronarde, Exercise-induced asthma, Curr. Opin. Pulm.Med. 15 (2009) 25-28.
8. D.S. Robinson, Regulatory T cells and asthma, Clin. Exp. Allergy 39 (2009) 1314-1323.
9. J.W. Holloway, I.A. Yang, S.T. Holgate, Genetics of allergic disease, J. Allergy Clin. Immunol. 125 (2 Suppl. 2) (2010) S81-S94.
10. J. Hopkin, Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links, Parasite Immunol. 31 (2009) 267-273.
11. H Yao, S.R. Yang, A. Kode, S. Rajendrasozhan, S. Caito, D. Adenuga, R. Henry, I. Edirisinghe, I. Rahman, Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signaling, Biochem. Soc. Trans. 35 (2007) 1151-1155. (Pubitemid 350206448)
12. T. Fujisawa, Role of oxygen radicals on bronchial asthma, Curr. Drug Targets Inflamm. Allergy 4 (2005) 505-509.
13. P.A. Henricks, F.P. Nijkamp, Reactive oxygen species as mediators in asthma, Pulm. Pharmacol. Ther. 14 (2001) 409-420.
14. S.T. Holgate, Pathogenesis of asthma, Clin. Exp. Allergy 38 (2008) 872-897.
15. A.M. Fitzpatrick, W.G. Teague, F. Holguin, M. Yeh, L.A. Brown, Severe asthma research program, airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress, J. Allergy Clin. Immunol. 123 (2009) 146-152.
16. U.C. Yadav, K.V. Ramana, Y.C. Awasthi, S.K. Srivastava, Glutathione level regulates HNE-induced genotoxicity in human erythroleukemia cells, Toxicol. Appl. Pharmacol. 227 (2008) 257-264.
17. S. Srivastava, A. Chandra, A. Bhatnagar, S.K. Srivastava, N.H. Ansari, Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase, Biochem. Biophys. Res. Commun. 217 (1995) 741-746.
18. S.K. Srivastava, K.V. Ramana, A. Bhatnagar, Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options, Endocr. Rev. 26 (2005) 380-392.
19. K.V. Ramana, A.A. Fadl, R. Tammali, A.B. Reddy, A.K. Chopra, S.K. Srivastava, Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages, J. Biol. Chem. 281 (2006) 33019-33029.
20. K.V. Ramana, A. Bhatnagar, S. Srivastava, U.C. Yadav, S. Awasthi, Y.C. Awasthi, S.K. Srivastava, Mitogenic responses of vascular smooth muscle cells to lipid peroxidationderived aldehydes 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth, J. Biol. Chem. 281 (2006) 17652-17660.
21. Y.M. Janssen-Heininger, M.E. Poynter, S.W. Aesif, C. Pantano, J.L. Ather, N.L. Reynaert, K. Ckless, V. Anathy, J. van der Velden, C.G. Irvin, A. van der Vliet, Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control, Proc. Am. Thorac. Soc. 6 (2009) 249-255.
22. C.S. Park, T.B. Kim, K.Y. Lee, K.A. Moon, Y.J. Bae, M.K. Jang, Y.S. Cho, H.B. Moon, Increased oxidative stress in the airway and development of allergic inflammation in a mouse model of asthma, Ann. Allergy Asthma Immunol. 103 (2009) 238-247.
23. M. Talati, B. Meyrick, R.S. Peebles Jr., S.S. Davies, R. Dworski, R. Mernaugh, D. Mitchell, M. Boothby, L.J. Roberts 2nd, J.R. Sheller, Oxidant stress modulates murine allergic airway responses, Free Radic. Biol. Med. 40 (2006) 1210-1219.
24. S.K. Srivastava, K.V. Ramana, Focus on molecules: nuclear factor-kappaB, Exp. Eye Res. 88 (2009) 2-3.
25. T. Lawrence, The nuclear factor NF-kappaB pathway in inflammation, Cold Spring Harb. Perspect. Biol. 1 (2009) a001651.
26. P. Subbarao, P.J. Mandhane, M.R. Sears, Asthma: epidemiology, etiology and risk factors, CMAJ 181 (2009) E181-E190.
27. J Ciencewicki, S. Trivedi, S.R. Kleeberger, Oxidants and the pathogenesis of lung diseases, J. Allergy Clin. Immunol. 122 (2008) 456-468.
28. H. Mochizuki, M. Todokoro, H. Arakawa, RS virus-induced inflammation and the intracellular glutathione redox state in cultured human airway epithelial cells, Inflammation 32 (2009) 252-264.
29. I. Boldogh, A. Bacsi, B.K. Choudhury, N. Dharajiya, R. Alam, T.K. Hazra, S. Mitra, R.M. Goldblum, S. Sur, ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation, J. Clin. Invest. 115 (2005) 2169-2179.
30. U.C. Yadav, K.V. Ramana, L. Aguilera-Aguirre, I. Boldogh, H.A. Boulares, S.K. Srivastava, Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice, PLoS One 4 (2009) e6535.
31. U.C. Yadav, A.S. Naura, L. Aguilera-Aguirre, K.V. Ramana, I. Boldogh, S. Sur, H.A. Boulares, S.K. Srivastava, Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice, J. Immunol. 183 (2009) 4723-4732.
32. I. Rahman, Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets, Curr. Drug Targets Inflamm. Allergy 1 (2002) 291-315.
33. P. Kirkham, I. Rahman, Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy, Pharmacol. Ther. 111 (2006) 476-494.
34. S.J. Park, Y.C. Lee, Antioxidants as novel agents for asthma, Mini Rev. Med. Chem. 6 (2006) 235-240.
35. W. Duan, J.H. Chan, C.H. Wong, B.P. Leung, W.S. Wong, Antiinflammatory effects of mitogen-activated protein kinase inhibitor U0126 in an asthma mouse model, J. Immunol. 172 (2004) 7053-7059. (Pubitemid 38669147)
36. W. Duan, A.M. Aguinaldo Datiles, B.P. Leung, C.J. Vlahos, W.S. Wong, An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model, Int. Immunopharmacol. 5 (2005) 495-502.
37. Z.S. Bao, S. Lim, W. Liao, Y. Lin, C. Thiemermann, B.P. Leung, W.S. Wong, Glycogen synthase kinase-3β inhibition attenuates asthma in mice, Am. J. Respir. Crit. Care Med. 176 (2007) 431-438. (Pubitemid 47358096)
38. W. Duan, J.H. Chan, K. McKay, J.R. Crosby, H.H. Choo, B.P. Leung, J.G. Karras, W.S. Wong, Inhaled p38α mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice, Am. J. Respir. Crit. Care Med. 171 (2005) 571-578.
39. W.R. Henderson Jr., E.Y. Chi, J.L. Teo, C. Nguyen, M. Kahn, A small molecule inhibitor of redox-regulated NF-κB and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthmamodel, J. Immunol. 169 (2002) 5294-5299. (Pubitemid 35217202)
40. S.C. Chue, C.J. Seow, W. Duan, K.S. Yeo, A.H. Koh, W.S. Wong, Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro, Int. Immunopharmacol. 4 (2002) 1089-1098.
41. K.V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, S.K. Srivastava, Activation of nulcear factor-B by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase, Diabetes 53 (2004) 2910-2920. (Pubitemid 39425917)
42. K.V. Ramana, A. Bhatnagar, S.K. Srivastava, Aldose reductase regulates TNF-α- induced cell signaling and apoptosis in vascular endothelial cells, FEBS Lett. 570 (2004) 189-194. (Pubitemid 38900980)
43. A. Pladzyk, A.B. Reddy, U.C. Yadav, R. Tammali, K.V. Ramana, S.K. Srivastava, Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells, Invest. Ophthalmol. Visual Sci. 47 (2006) 5395-5403. (Pubitemid 46723790)
44. N. Hotta, T. Toyota, K. Matsuoka, Y. Shigeta, R. Kikkawa, T. Kaneko, A. Takahashi, K. Sugimura, Y. Koike, J. Ishii, N. Sakamoto, SNK-860 Diabetic Neuropathy Study Group, Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study, Diabetes Care 24 (2001) 1776-1782.
45. M.A Ramirez, N.L. Borja, Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy, Pharmacotherapy 28 (2008) 646-655. (Pubitemid 351620031)